Reactive oxygen species in pathogenesis of atherosclerosis

Current Pharmaceutical Design

Volumn 21, Issue 9, 2015, Pages 1134-1146

  Goncharov, Nikolay V ^a,b   Avdonin, Pavel V ^c   Nadeev, Alexander D ^d   Zharkikh, Irina L ^e   Jenkins, Richard O ^f  

^a SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

^b Research Institute of Hygiene   (Russian Federation)

^c KOL TSOV INSTITUTE OF DEVELOPMENTAL BIOLOGY   (Russian Federation)

^d INSTITUTE OF CELL BIOPHYSICS   (Russian Federation)

^e INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

^f DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

Cyclooxygenase; Cytochrome P450; Hemoglobin; NADPH oxidase; NO synthase; Peroxidase; Xanthine oxidase

Indexed keywords

CYTOCHROME P450; HEMOGLOBIN; LIPOXYGENASE; NITRIC OXIDE SYNTHASE; PEROXIDASE; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; XANTHINE OXIDASE;

ARTICLE; ATHEROSCLEROSIS; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; CARDIOVASCULAR RISK; DEFENSE MECHANISM; ERYTHROCYTE; HUMAN; MITOCHONDRION; NONHUMAN; PATHOGENESIS; POSITIVE FEEDBACK; PRIORITY JOURNAL; REGULATORY MECHANISM; VASCULAR DISEASE; VASCULAR REMODELING; METABOLISM; PATHOLOGY; RISK FACTOR;

ATHEROSCLEROSIS; CYTOCHROME P-450 ENZYME SYSTEM; ERYTHROCYTES; HEMOGLOBINS; HUMANS; LIPOXYGENASES; MITOCHONDRIA; NADPH OXIDASE; NITRIC OXIDE SYNTHASE; PEROXIDASES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REACTIVE OXYGEN SPECIES; RISK FACTORS; XANTHINE OXIDASE;

EID: 84925854840     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612820666141014142557     Document Type: Article

References (204)

1. Baldrige CW, Gerard RW. The extra respiration of phagocytosis. AJP-Legacy 1932; 103: 235-6.
2. Vara D, Pula G. Reactive Oxygen Species: Physiological Roles in the Regulation of Vascular Cells. Curr Mol Med. 2014. Jun 3. [Epub ahead of print].
3. Shappell SB, Toman C, Anderson DC, et al. Mac-1 (CD11b/CD18) mediates adherence-dependent hydrogen peroxide production by human and canine neutrophils. J Immunol 1990; 144(7): 2702-11.
4. Jones DP. Radical-free biology of oxidative stress. Am J Physiol Cell Physiol 2008; 295 (4), C849-8.
5. Liu H, Colavitti R, Rovira II, Finkel T. Redox-dependent transcriptional regulation. Circ Res 2005; 97: 967-74.
6. Magder S. Reactive oxygen species: toxic molecules or spark of life? Crit Care 2006; 10: 208.
7. Janero DR, Hreniuk D. Suppression of TCA cycle activity in the cardiac muscle cell by hydroperoxide-induced oxidant stress. Am J Physiol 1996; 270 (6 Pt 1), C1735-42.
8. Lubrano V, Balzan S. LOX-1 and ROS, inseparable factors in the process of endothelial damage. Free Radic Res. 2014 Jun 23: 1-8.[Epub ahead of print]].
9. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 2000; 279(6): L1005-28.
10. Petry A, Weitnauer M, Görlach A. Receptor activation of NADPH oxidases. Antioxid Redox Signal 2010; 13(4): 467-87.
11. Miller EW, Dickinson BC, Chang CJ. Aquaporin-3 mediates hydrogen peroxide uptake to regulate downstream intracellular signaling. Proc Natl Acad Sci USA 2010; 107: 15681-6.
12. Proctor P. Electron-transfer factors in psychosis and dyskinesia. Physiol Chem Phys 1972; 4 (4): 349-60.
13. Proctor P, Reynolds E. Free radicals and disease in man. Physiol Chem and Phys Med NMR 1984; 16(3): 175-95.
14. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004; 4(3): 181-89.
15. Konior A, Schramm A, Czesnikiewicz-Guzik M, Guzik TJ. NADPH oxidases in vascular pathology. Antioxid Redox Signal 2014; 20(17): 2794-814.
16. Muzykantov VR, Sakharov DV, Domogatsky SP, Goncharov NV, Danilov SM. Directed targeting of immunoerythrocytes provides local protection of endothelial cells from damage by hydrogen peroxide. Am J Pathol 1987; 128(2): 276-85.
17. Zaki ME, El-Bassyouni H, Kamal S, et al. Association of serum paraoxonase enzyme activity and oxidative stress markers with dyslipidemia in obese adolescents. Indian J Endocrinol Metab 2014; 18(3): 340-4.
18. Kragh-Hansen U. Molecular and practical aspects of the enzymatic properties of human serum albumin and of albumin-ligand complexes. Biochim Biophys Acta. 2013; 1830(12): 5535-44.
19. Lau D, Baldus S. Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacol Ther 2006; 111: 16-26.
20. White CR, Darley-Usmar V, Berrington WR, et al. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc Natl Acad of Sci USA 1996; 93: 8745-9.
21. Mohanty JG, Nagababu E, Rifkind JM. Red blood cell oxidative stress impairs oxygen delivery and induces red blood cell aging. Front Physiol 2014; 5: 84.
22. Drummond GR, Selemidis S, Griendling KK, Sobey CG. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov. 2011; 10(6): 453-71.
23. Segal AW. How neutrophils kill microbes. Annu Rev Immunol 2005; 23: 197-223.
24. Hilenski LL, Clempus RE, Quinn MT, et al. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2004; 24: 677-83.
25. Gavazzi G, Banfi B, Deffert C, et al. Decreased blood pressure in NOX1-deficient mice. FEBS Lett 2006; 580: 497-504.
26. Matsuno K, Yamada H., Iwata K, et al. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation 2005; 112: 2677-85.
27. Garrido AM, Griendling KK. NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol 2009; 302: 148-58.
28. Dikalova AE, Góngora MC, Harrison DG, et al. Upregulation of Nox1 in vascular smooth muscle leads to impaired endotheliumdependent relaxation via eNOS uncoupling. Am J Physiol Heart Circ Physiol 2010; 299(3): H673-9
29. McNally JS, Davis ME, Giddens DP, et al. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol Heart Circ Physiol 2003; 285: H2290-7.
30. Faurschou M., Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 2003; 5: 1317-1327
31. Ha YJ, Seul HJ, Lee JR. Ligation of CD40 receptor in human B lymphocytes triggers the 5-lipoxygenase pathway to produce reactive oxygen species and activate p38 MAPK. Exp Mol Med 2011; 28; 43(2): 101-10.
32. Xia M, Li G, Ma J, Ling W. Phosphoinositide 3-kinase mediates CD40 ligand-induced oxidative stress and endothelial dysfunction via Rac1 and NADPH oxidase 2. J Thromb Haemost 2010 Feb; 8(2): 397-406.
33. Bhogal RH, Weston CJ, Curbishley SM, et al. Activation of CD40 with platelet derived CD154 promotes reactive oxygen species dependent death of human hepatocytes during hypoxia and reoxygenation. PLoS One. 2012; 7(1): e30867.
34. Yang L, Zhang J, Yan C, et al. Expression Induced by TNF-αvia NF-κB Pathway in Endothelial Cells. Cell Physiol Biochem 2012; 30(5): 1287-98.
35. Youn JY, Gao L, Cai H. The p47phox-and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes. Diabetologia 2012; 55(7): 2069-79.
36. Sumimoto H 2008. Structure, regulation and evolution of Noxfamily NADPH oxidases that produce reactive oxygen species. FEBS J; 275: 3249-3277
37. Kuroda J, Nakagawa K, Yamasaki T, et al. The superoxideproducing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells. Genes Cells 2005; 10: 1139-51.
38. Brown DI, Griendling KK . Nox proteins in signal transduction. Free Radic Biol Med 2009; 47; 1239-53.
39. Clempus RE, Sorescu D, Dikalova AE, et al. Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 2007; 27: 42-8.
40. Lee Y.M., Kim B.J., Chun Y.S., et al. NOX4 as an oxygen sensor to regulate TASK-1 activity. Cell Signal 2006; 18: 499-507.
41. Sylvester JT, Shimoda LA, Aaronson PI, Ward JP. Hypoxic pulmonary vasoconstriction. Physiol Rev 2012; 92: 367-520.
42. Martyn KD, Frederick LM, von Loehneysen K, et al. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal 2006; 18(1): 69-82.
43. Helmcke I, Heumüller S, Tikkanen R, et al. Identification of structural elements in Nox1 and Nox4 controlling localization and activity. Antioxid Redox Signal 2009; 11(6): 1279-87.
44. Mahadev K, Motoshima H., Wu X, et al. The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol Cell Biol 2004; 24: 1844-54.
45. Ben Mkaddem S, Pedruzzi E, Werts C, et al. Heat shock protein gp96 and NAD(P)H oxidase 4 play key roles in Toll-like receptor 4-activated apoptosis during renal ischemia/reperfusion injury. Cell Death Differ 2010; 17(9): 1474-85.
46. Suzuki Y, Hattori K, Hamanaka J, et al. Pharmacological inhibition of TLR4-NOX4 signal protects against neuronal death in transient focal ischemia. Sci Rep 2012; 2: 896.
47. Sturrock A, Cahill B, Norman K, et al. Transforming growth factor {beta}1 induces Nox 4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2006; 290(4): L661-73.
48. Hu T, Ramachandrarao SP, Siva S, et al. Reactive oxygen species production via NADPH oxidase mediates TGF-beta-induced cytoskeletal alterations in endothelial cells. Am J Physiol Renal Physiol 2005; 289: F816-825.
49. Pedruzzi E, Guichard C, Ollivier V, et al. NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. Mol Cell Biol 2004; 24: 10703-17.
50. Xu S, Chamseddine AH, Carrell S, Miller FJ Jr. Nox4 NADPH oxidase contributes to smooth muscle cell phenotypes associated with unstable atherosclerotic plaques. Redox Biol 2014; 2: 642-50/
51. Geiszt M, Witta J, Baffi J, et al 2003. Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J 2003; 17: 1502-04.
52. Ris-Stalpers C. Physiology and pathophysiology of the DUOXes. Antioxid Redox Signal 2006; 8(9-10): 1563-72
53. Yoshihara A, Hara T, Kawashima A, et al. Regulation of dual oxidase expression and H2O2 production by thyroglobulin. Thyroid. 2012; 22(10): 1054-62.
54. Ohye H, Sugawara M. Dual oxidase, hydrogen peroxide and thyroid diseases. Exp Biol Med (Maywood). 2010; 235(4): 424-33.
55. Kilic ID, Tanriverdi H, Fenkci S, et al. Noninvasive indicators of atherosclerosis in subclinical hypothyroidism. Indian J Endocrinol Metab. 2013; 17(2): 271-5.
56. Wang P, Xu TY, Guan YF, et al. Vascular smooth muscle cell apoptosis is an early trigger for hypothyroid atherosclerosis. Cardiovasc Res 2014; 102(3): 448-59.
57. Giorgio M, Migliaccio E, Orsini F, et al. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005; 122: 221-33.
58. Brand MD. The sites and topology of mitochondrial superoxide production. Exp Gerontol 2010; 45: 466-72.
59. Wang Y, Tabas I. Emerging Roles of Mitochondria ROS in Atherosclerotic Lesions: Causation or Association? J Atheroscler Thromb. 2014 27; 21(5): 381-90.
60. Pamukcu B, Lip GY, Shantsila E. The nuclear factor-kappa B pathway in atherosclerosis: a potential therapeutic target for atherothrombotic vascular disease. Thromb Res 2011; 128(2): 117-23.
61. Tsukimori K, Fukushima K, Tsushima A, Nakano H. Generation of reactive oxygen species by neutrophils and endothelial cell injury in normal and preeclamptic pregnancies. Hypertension 2005; 46(4): 696-700.
62. Wang Y, Wang GZ, Rabinovitch PS, Tabas I. Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-κB-mediated inflammation in macrophages. Circ Res. 2014; 114(3): 421-33.
63. Boueiz A. Hassoun PM. Regulation of endothelial barrier function by reactive oxygen and nitrogen species. Microvasc Res 2009; 77: 26-34.
64. Huppert J. Closhen D. Croxford A., et al. Cellular mechanisms of IL-17-induced blood-brain barrier disruption. FASEB J 2010; 24: 1023-34.
65. Yu E. Mitochondrial DNA Damage can Promote Atherosclerosis Independently of Reactive Oxygen Species and Correlates with Higher Risk Plaques in Humans. Heart. 2014; 100 (Suppl 3): A128-9.
66. Waud WR, Rajagopalan KV. The mechanism of conversion of rat liver xanthine dehydrogenase from an NAD+-dependent form (type D) to an O2-dependent form (type O). Arch Biochem Biophys 1976; 172: 365-79.
67. Amaya Y, Yamazaki K, Sato M, Noda K, Nishino T. Proteolytic conversion of xanthine dehydrogenase from the NAD-dependent type to the O2-dependent type. Amino acid sequence of rat liver xanthine dehydrogenase and identification of the cleavage sites of the enzyme protein during irreversible conversion by trypsin. J Biol Chem 1990; 265: 14170-5.
68. Harris CM, Massey V. The reaction of reduced xanthine dehydrogenase with molecular oxygen. Reaction kinetics and measurement of superoxide radical. J Biol Chem 1997; 272: 8370-9.
69. Enroth C, Eger BT, Okamoto K, Nishino T, Pai EF. Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: structure-based mechanism of conversion. Proc Natl Acad Sci USA 2000; 97: 10723-8.
70. Czupryna J, Tsourkas A. Xanthine oxidase-generated hydrogen peroxide is a consequence, not a mediator of cell death. EBS J 2012; 279(5): 844-55.
71. Nomura J, Busso N, Ives A, et al. Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice. Sci Rep 2014; 4: 4554.
72. Houston M, Estevez A, Chumley P, et al. Binding of xanthine oxidase to vascular endothelium. Kinetic characterization and oxidative impairment of nitric oxide-dependent signaling. J Biol Chem 1999; 274(8): 4985-94.
73. Malik UZ, Hundley NJ, Romero G, Radi R, et al. Febuxostat inhibition of endothelial-bound XO: implications for targeting vascular ROS production. Free Radic Biol Med 2011; 51(1): 179-84.
74. Fleming I. Cytochrome P450 enzymes in vascular homeostasis. Circ Res 2001; 89: 753-62.
75. Fisslthaler B, Michaelis UR, Randriamboavonjy V, Busse R, Fleming I. Cytochrome p450 epoxygenases and vascular tone: novel role for HMG-CoA reductase inhibitors in the regulation of CYP2C expression. Biochim Biophys Acta 2003; 1619: 332-9.
76. Fleming I, Michaelis UR, Bredenkötter D, et al. Endotheliumderived hyperpolarizing factor synthase (cytochrome p450 2C9) is a functionally significant source of reactive oxygen species in coronary artery. Circ Res 2001; 88: 44-51.
77. Fichtlscherer S, Dimmeler S, Breuer S, et al. Inhibition of cytochrome p450 2C9 improves endothelium-dependent, nitric oxidemediated vasodilatation in patients with coronary artery disease. Circulation 2004; 109: 178-83.
78. Sasaki M, Ostanin D, Elrod JW, et al. TNF-α-induced endothelial cell adhesion molecule expression is cytochrome p-450 monooxygenase dependent. Am J Physiol Cell Physiol 20003; 284: C422-8.
79. Chen X, Andresen1 BT, Hill M, Zhang J, Booth F, Zhang C. Role of Reactive Oxygen Species in Tumor Necrosis Factor-alpha Induced Endothelial Dysfunction. Curr Hypertens Rev 2008; 4(4): 245-55.
80. Kudryavtsev IV, Garnyuk VV, Nadeev AD, Goncharov NV. Hydrogen peroxide modulates expression of surface antigens by human umbilical vein endothelial cells in vitro. Biochemistry (Moscow) Supp. S. A: Membrane and Cell Biology, 2014, 8 (1): 97-102.
81. Bertrand-Thiebault C, Masson C, Siest G, Batt AM, Visvikis-Siest S. Effect of HMGCoA reductase inhibitors on cytochrome P450 expression in endothelial cell line. J Cardiovasc Pharmacol 2007; 49(5): 306-15.
82. Thum T, Borlak J. Mechanistic role of cytochrome p450 monooxygenases in oxidized low-density lipoprotein-induced vascular injury: therapy through LOX-1 receptor antagonism? Circ Res 2004; 94: e1-e13.
83. Verhaar MC, Westerweel PE, van Zonneveld AJ, Rabelink TJ. Free radical production by dysfunctional eNOS. Heart. 2004; 90 (5): 494-5.
84. Sánchez A, Contreras C, Martínez MP, et al. Role of neural NO synthase (nNOS) uncoupling in the dysfunctional nitrergic vasorelaxation of penile arteries from insulin-resistant obese Zucker rats. PLoS One. 2012; 7(4): e36027.
85. Kar S, Kavdia M. Modeling of biopterin-dependent pathways of eNOS for nitric oxide and superoxide production. Free Radic Biol Med 2011; 51(7): 1411-27.
86. Huang H, Koelle P, Fendler M, et al. Induction of inducible nitric oxide synthase (iNOS) expression by oxLDL inhibits macrophage derived foam cell migration. Atherosclerosis. 2014; 235(1): 213-22.
87. Freed JK, Beyer AM, LoGiudice JA, Hockenberry JC, Gutterman DD. Ceramide Changes the Mediator of Flow-Induced Vasodilation from Nitric Oxide to Hydrogen Peroxide in the Human Microcirculation. Circ Res 2014 Jun 11.[Epub ahead of print]].
88. Zamocky M, Jakopitsch C, Furtmüller PG, Dunand C, Obinger C. The peroxidase-cyclooxygenase superfamily: Reconstructed evolution of critical enzymes of innate immune system. Proteins 2008; 72(2): 589-605.
89. Furtmüller PG, Zederbauer M, Jantschko W, et al. Active site structure and catalytic mechanisms of human peroxidases. Arch Biochem. Biophys.2006; 445(2): 199-213.
90. Heinecke JW, Li W, Francis GA, Goldstein JA. Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. J Clin Invest 1993; 91(6): 2866-72.
91. Sokolov AV, Kostevich VA, Runova OL, et al. Proatherogenic modification of LDL by surface-bound myeloperoxidase. Chem Phys Lipids 2014; 180: 72-80.
92. Haraguchi Y, Toh R, Hasokawa M, et al. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease. Atherosclerosis 2014; 234(2): 288-94.
93. Shao B, Tang C, Sinha A, et al. Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase. Circ Res. 2014; 114(11): 1733-42.
94. Dickerhof N, Magon NJ, Tyndall JD, Kettle AJ, Hampton MB. Potent inhibition of macrophage migration inhibitory factor (MIF) by myeloperoxidase (MPO)-dependant oxidation of epicatechins. Biochem J 2014. [Epub ahead of print]
95. Piatt J, O'Brien PJ. Singlet oxygen formation by a peroxidase, H2O2 and halide system. Eur J Biochem 1979; 93(2): 323-32.
96. Wever R, Kast WM, Kasinoedin JH, Boelens R. The peroxidation of thiocyanate catalysed by myeloperoxidase and lactoperoxidase. Biochim Biophys Acta 1982; 709 (2): 212-9.
97. Carlsson J, Edlund MB, Hänström L (1984). "Bactericidal and cytotoxic effects of hypothiocyanite-hydrogen peroxide mixtures". Infect Immun 1984; 44 (3): 581-6.
98. Ghibaudi EM, Laurenti E, Beltramo P, Ferrari RP. Can estrogenic radicals, generated by lactoperoxidase, be involved in the molecular mechanism of breast carcinogenesis? Redox Rep 2000; 5(4): 229-35.
99. Gorlewska-Roberts KM, Teitel CH, Lay JO, Roberts DW, Kadlubar FF. Lactoperoxidase-catalyzed activation of carcinogenic aromatic and heterocyclic amines". Chem. Res. Toxicol 2004; 17 (12): 1659-66.
100. Harrison JE, Saeed FA. Radical acetoacetate oxidation by myeloperoxidase, lactoperoxidase, prostaglandin synthetase, and prostacyclin synthetase: implications for atherosclerosis. Biochem Med 1983; 29(2): 149-63.
101. Mayeno AN, Curran AJ, Roberts RL, Foote CS. Eosinophils preferentially use bromide to generate halogenating agents. J Biol Chem 1989; 264 (10): 5660-8.
102. Ten RM, Pease LR, McKean DJ, Bell MP, Gleich GJ. Molecular cloning of the human eosinophil peroxidase. Evidence for the existence of a peroxidase multigene family J Exp Med 1989; 169 (5): 1757-69.
103. Nagata M. Inflammatory cells and oxygen radicals. Curr Drug Targets Inflamm Allergy 2005; 4(4): 503-4;
104. Trillo AA. The cell population of aortic fatty streaks in African green monkeys with special reference to granulocytic cells. An ultrastructural study. Atherosclerosis 1982; 43(2-3): 259-75.
105. Fukui M, Tanaka M, Hamaguchi M, et al. Eosinophil count is positively correlated with albumin excretion rate in men with type 2 diabetes. Clin J Am Soc Nephrol. 2009; 4(11): 1761-5.
106. Gupta K, Selinsky BS, Kaub CJ, Katz AK, Loll PJ. The 2.0 A resolution crystal structure of prostaglandin H2 synthase-1: structural insights into an unusual peroxidase. J Mol Biol 2004; 335(2): 503-18.
107. Jaimes EA, Hua P, Tian RX, Raij L. Human glomerular endothelium: interplay among glucose, free fatty acids, angiotensin II, and oxidative stress. Am J Physiol Renal Physiol 2010; 298(1): F125-32.
108. Chen CC, Cheng YY, Chen SC, Tuan YF, Chen YJ, Chen CY, Chen LC. Cyclooxygenase-2 expression is up-regulated by 2-aminobiphenyl in a ROS and MAPK-dependent signaling pathway in a bladder cancer cell line. Chem Res Toxicol 2012; 25(3): 695-705.
109. Kunz A, Anrather J, Zhou P, Orio M, Iadecola C. Cyclooxygenase-2 does not contribute to postischemic production of reactive oxygen species. J Cereb Blood Flow Metab 2007; 27(3): 545-51.
110. Holland JA, Pritchard KA, Pappolla MA, et al. Bradykinin induces superoxide anion release from human endothelial cells. J Cell Physiol 1990; 143: 21-5.
111. Ahmed S, Gul S, Gul H, Zia-Ul-Haq M, Ercisli S. Cyclooxygenase-2 inhibition improves antioxidative defense during experimental hypercholesterolemia. Bosn J Basic Med Sci. 2014; 14(2): 63-9.
112. Kirkby NS, Lundberg MH, Wright WR, et al. COX-2 Protects against Atherosclerosis Independently of Local Vascular Prostacyclin: Identification of COX-2 Associated Pathways Implicate Rgl1 and Lymphocyte Networks. PLoS One. 2014; 9(6): e98165.
113. Tang SY, Monslow J, Todd L, Lawson J, Puré E, FitzGerald GA. Cyclooxygenase-2 in endothelial and vascular smooth muscle cells restrains atherogenesis in hyperlipidemic mice. Circulation. 2014; 129(17): 1761-9.
114. Kraus S, Naumov I, Shapira S, et al. Aspirin but not meloxicam attenuates early atherosclerosis in apolipoprotein E knockout mice. Isr Med Assoc J 2014; 16(4): 233-8.
115. Cho KJ, Seo JM, Kim JH. Bioactive lipoxygenase metabolites stimulation of NADPH oxidases and reactive oxygen species. Mol Cells 2011; 32(1): 1-5.
116. Anwar Y, Sabir JS, Qureshi MI, Saini KS. 5-lipoxygenase: a promising drug target against inflammatory diseases-biochemical and pharmacological regulation. Curr Drug Targets 2014; 15(4): 410-22.
117. Czapski GA, Czubowicz K, Strosznajder RP. Evaluation of the antioxidative properties of lipoxygenase inhibitors. Pharmacol Rep 2012; 64(5): 1179-88.
118. Chen W, Lin YC, Ma XY, Jiang ZY, Lan SP. High concentrations of genistein exhibit pro-oxidant effects in primary muscle cells through mechanisms involving 5-lipoxygenase-mediated production of reactive oxygen species. Food Chem Toxicol 2014; 67-72.
119. Weaver JR, Holman TR, Imai Y, et al. Integration of proinflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunction. Mol Cell Endocrinol 2012; 358(1): 88-95.
120. Kotla S, Singh NK, Heckle MR, Tigyi GJ, Rao GN. The transcription factor CREB enhances interleukin-17A production and inflammation in a mouse model of atherosclerosis. Sci Signal 2013; 6(293): ra83.
121. Sidell B, O'Brien K. When bad things happen to good fish: the loss of hemoglobin and myoglobin expression in Antarctic icefishes. J Exp Biol 2006; 209(Pt 10): 1791-802.
122. Weed RI; Reed CF, Berg G. Is hemoglobin an essential structural component of human erythrocyte membranes? J Clin Invest 1963; 42(4): 581-8.
123. Gunsalus IC, Sligar SG, Nordlund T, Frauenfelder H. Oxygen sensing heme proteins: monoxygenases, myoglobin and hemoglobin. Adv Exp Med Biol 1977; 78: 37-50.
124. Lopez-Barneo J, Ortega-Saenz P, Molina A, Franco-Obregon A, Urena J, Castellano A. Oxygen sensing by ion channels. Kidney Int 51: 454-461, 1997;
125. Acker T, Fandrey J, Acker H. The good, the bad and the ugly in oxygen-sensing: ROS, cytochromes and prolyl-hydroxylases. Cardiovasc Res 2006; 71: 195-207.
126. Ryter SW, Tyrrell RM. The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both proand antioxidant properties. Free Radic Biol Med 2000; 28: 289-309.
127. Abugo OO, Rifkind JM. Oxidation of hemoglobin and the enhancement produced by nitroblue tetrazolium. J Biol Chem 1994; 269, 24845-53.
128. Silva G, Jeney V, Chora A, et al. Oxidized hemoglobin is an endogenous proinflammatory agonist that targets vascular endothelial cells. J Biol Chem 2009; 284: 29582-95.
129. Balagopalakrishna C, Manoharan PT, Abugo OO, Rifkind JM. Production of superoxide from hemoglobin-bound oxygen under hypoxic conditions. Biochemistry 1996; 35: 6393-8.
130. Cao Z, Bell JB, Mohanty JG, Nagababu E, Rifkind JM. Nitrite enhances RBC hypoxic ATP synthesis and the release of ATP into the vasculature: a new mechanism for nitrite-induced vasodilation. Am J Physiol Heart Circ Physiol 2009; 297: H1494-503.
131. Nagababu E., Gulyani S., Earley CJ, et al. Iron-deficiency anaemia enhances red blood cell oxidative stress. Free Radic. Res 208; 42, 824-9.
132. Kiefmann R, Rifkind JM, Nagababu E, Bhattacharya J. Red blood cells induce hypoxic lung inflammation. Blood 2008; 111, 5205-14.
133. Huertas A, Das SR, Emin M, et al. Erythrocytes induce proinflammatory endothelial activation in hypoxia. Am J Respir Cell Mol Biol 2013; 48, 78-86.
134. Gurbuz N, Yalcin O, Aksu TA, Baskurt OK. The relationship between the enzyme activity, lipid peroxidation and red blood cells deformability in hemizygous and heterozygous glucose-6-phosphate dehydrogenase deficient individuals. Clin Hemorheol Microcirc 2004; 31, 235-42.
135. Chasis JA, Mohandas N. Erythrocyte membrane deformability and stability: two distinct membrane properties that are independently regulated by skeletal protein associations. J Cell Biol 1986; 103, 343-50.
136. Suzuki Y, Ohkubo N, Aoto M, et al. Participation of caspase-3-like protease in oxidation-induced impairment of erythrocyte membrane properties. Biorheology 2007; 44, 179-90.
137. Grau M, Pauly S, Ali J, et al. RBC-NOS-dependent S-nitrosylation of cytoskeletal proteins improves RBC deformability. PLoS ONE 2013; 8: e56759.
138. Mandal D, Baudin-Creuza V, Bhattacharyya A, et al. (2003). Caspase 3-mediated proteolysis of the N-terminal cytoplasmic domain of the human erythroid anion exchanger 1 (band 3). J Biol Chem 2003; 2786 52551-8.
139. Mandal D, Mazumder A, Das P, Kundu M, Basu J. Fas-, caspase 8-, and caspase 3-dependent signaling regulates the activity of the aminophospholipid translocase and phosphatidylserine externalization in human erythrocytes. J Biol Chem 2005; 280: 39460-7
140. Grey JL, Kodippili GC, Simon K, Low PS. Identification of contact sites between ankyrin and band 3 in the human erythrocyte membrane. Biochemistry 2012; 51: 6838-46.
141. Mindukshev IV, Senchenkova EY, Goncharov NV, Vivulanets EV, Krivoshlyk VV. New methods for studying platelets and red blood cells, based upon the low-angle light scattering technique. In: Hemorheology: Blood Flow, Disturbance and Prognosis. Ed.F.Columbus, NY, Nova Science Publishers 2010; 87-124.
142. Fens MH, van Wijk R, Andringa G, et al. A role for activated endothelial cells in red blood cell clearance: implications for vasopathology. Haematologica 2012; 97: 500-8.
143. Kiefer CR, Snyder LM. Oxidation and erythrocyte senescence. Curr Opin Hematol 2000; 7: 113-6.
144. Barodka V, Mohanty JG, Mustafa AK, et al. Nitroprusside inhibits calcium-induced impairment of red blood cell deformability. Transfusion 2013; 54: 434-44.
145. Mindukshev IV, Krivoshlyk VV, Ermolaeva EE, et al. Necrotic and apoptotic volume changes of red blood cells investigated by low-angle light scattering technique. Spectroscopy Int J 2007; 21(2): 105-20.
146. Redding GS, Record DM, Raess BU. Calcium-stressed erythrocyte membrane structure and function for assessing glipizide effects on transglutaminase activation. Proc Soc Exp Biol Med 1991; 196, 76-82.
147. Zipser Y, Piade A, Barbul A, Korenstein R, Kosower NS. Ca2+ promotes erythrocyte band 3 tyrosine phosphorylation via dissociation of phosphotyrosine phosphatase from band 3. Biochem J 2002; 368, 137-44.
148. Farbstein D, Soloveichik YZ, Levy NS, Levy AP. Genetics of redox systems and their relationship with cardiovascular disease. Curr Atheroscler Rep 2011; 13: 215-24.
149. Martin-Ventura JL, Madrigal-Matute J, Martinez-Pinna R, et al. Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: detoxifying mechanisms and potential therapeutic options. Thromb Haemost 2012; 108(3): 435-42.
150. Nagy E, Eaton JW, Jeney V, et al. Red cells, hemoglobin, heme, iron, and atherogenesis. Arterioscler Thromb Vasc Biol 2010; 30: 1347-53.
151. Boyle JJ, Johns M, Lo J, et al. Heme Induces Heme Oxygenase 1 via Nrf2: Role in the Homeostatic Macrophage Response to Intraplaque Hemorrhage. Arterioscler Thromb Vasc Biol 2011; 31: 2685-91.
152. Finn AV, Nakano M, Polavarapu R, et al. Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques. J Am Coll Cardiol 2012; 59: 166-77.
153. Watanabe J, Chou KJ, Liao JC, et al. Differential association of hemoglobin with proinflammatory high density lipoproteins in atherogenic/hyperlipidemic mice. A novel biomarker of atherosclerosis. J Biol Chem 2007; 282: 23698-707.
154. Crawford JH, Isbell TS, Huang Z, et al. Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation. Blood 2006; 107: 566-74.
155. Minneci PC, Deans KJ, Shiva S, et al. Nitrite reductase activity of hemoglobin as a systemic nitric oxide generator mechanism to detoxify plasma hemoglobin produced during hemolysis. Am J Physiol Heart Circ Physiol 2008; 295: H743-54.
156. Jeney V, Balla J, Yachie A, et al. Pro-oxidant and cytotoxic effects of circulating heme. Blood 2002; 100: 879-87.
157. Ball RY, Bindman JP, Carpenter KL, Mitchinson MJ Oxidized low density lipoprotein induces ceroid accumulation by murine peritoneal macrophages in vitro. Atherosclerosis 1986; 60: 173-81.
158. Ball RY, Carpenter KL, Mitchinson MJ. What is the significance of ceroid in human atherosclerosis? Arch Pathol Lab Med 1987; 111: 1134-40.
159. Lee FY, Lee TS, Pan CC, et al. Colocalization of iron and ceroid in human atherosclerotic lesions. Atherosclerosis 1998; 138: 281-8.
160. Haka AS, Kramer JR, Dasari RR, Fitzmaurice M. Mechanism of ceroid formation in atherosclerotic plaque: in situ studies using a combination of Raman and fluorescence spectroscopy. J Biomed Opt 2011; 16: 011011.
161. Brissot P, Ropert M, Le Lan C, Loréal O. Non-transferrin bound iron: A key role in iron overload and iron toxicity. Biochim Biophys Acta 2012; 1820: 403-10.
162. Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 2012; 24: 981-90.
163. Stadler N, Lindner RA, Davies MJ. Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper. Arterioscler Thromb Vasc Biol 2004; 24: 949-54.
164. Stanley N, Stadler N, Woods AA, Bannon PG, Davies MJ. Concentrations of iron correlate with the extent of protein, but not lipid, oxidation in advanced human atherosclerotic lesions. Free Radic Biol Med 2006; 40: 1636-43.
165. Nchimi A, Defawe O, Brisbois D, et al. MR imaging of iron phagocytosis in intraluminal thrombi of abdominal aortic aneurysms in humans. Radiology 2010; 254: 973-81.
166. Leopold JA, Loscalzo J. Oxidative enzymopathies and vascular disease. Arterioscler Thromb Vasc Biol 2005; 25(7): 1332-40.
167. Gardner PR, Nguyen DD, White CW. Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells and in rat lungs. Proc Natl Acad Sci USA 1994; 91 (25): 12248-52.
168. Mohr S, Hallak H, de Boitte A, Lapetina EG, Brüne B. Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 1999; 274 (14), 9427-30.
169. Matsuda M, Shimomura I. Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obes Res Clin Pract. 2013; 7(5): e330-41.
170. Nemoto S, Takeda K, Yu ZX, Ferrans VJ, Finkel T. Role for mitochondrial oxidants as regulators of cellular metabolism. Mol Cell Biol 2000; 20: 7311-8.
171. Brunelle JK, Bell EL, Quesada NM, et al. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab 2005; 1: 409-14.
172. Mansfield KD, Guzy RD, Pan Y, et al. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation. Cell Metab 2005; 1: 393-9.
173. Scherz-Shouval R, Shvets E, Fass E, et al. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 2007; 26: 1749-60.
174. Bulua AC, Simon A, Maddipati R, et al. Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). J Exp Med 2011; 208: 519-33.
175. Nakahira K, Haspel JA, Rathinam VA, et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 2011; 12: 222-30.
176. Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011; 469: 221-5.
177. Rus HG, Niculescu F, Vlaicu R. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis 1991; 89: 247-54.
178. Buono C, Come CE, Stavrakis G, et al. Influence of interferongamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arterioscler Thromb Vasc Biol 2003; 23: 454-60.
179. Kirii H, Niwa T, Yamada Y, et al. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2003; 23: 656-60.
180. Razani B, Feng C, Coleman T, et al. Autophagy links inflammasomes to atherosclerotic progression. Cell Meta. 2012; 15(4): 534-44.
181. Liao X, Sluimer JC, Wang Y, et al. Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab. 2012; 15(4): 545-53.
182. Alom-Ruiz SP, Anilkumar N, Shah AM. Reactive oxygen species and endothelial activation. Antioxid Redox Signal 2008; 10: 1089-1100
183. van Hinsbergh VW. Endothelium-role in regulation of coagulation and inflammation. Semin Immunopathol 2012; 34(1): 93-106.
184. Libby P, Plutzky J. Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists. Am J Cardiol 2007; 99: 27B-40B.
185. Garcia-Cardena G, Gimbrone MA Jr. Biomechanical modulation of endothelial phenotype: implications for health and disease. Handb Exp Pharmacol 2006; 79-95.
186. Fischer B, von Knethen A, Brune B. Dualism of oxidized lipoproteins in provoking and attenuating the oxidative burst in macrophages: role of peroxisome proliferator-activated receptor-gamma. J Immunol 2002; 168: 2828-34.
187. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-74.
188. Galkina E, Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 2007; 27: 2292-01.
189. Kisucka J, Chauhan AK, Patten IS, et al. Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis. Circ Res 2008; 103(6): 598-605.
190. Vischer UM, Jornot L, Wollheim CB, Theler JM. Reactive oxygen intermediates induce regulated secretion of von Willebrand factor from cultured human vascular endothelial cells. Bloo 1995; 85: 3164-72.
191. Lowenstein CJ, Morrell CN, Yamakuchi M. Regulation of Weibel-Palade body exocytosis. Trends Cardiovasc Med 2005; 15: 302-8.
192. Dole VS, Bergmeier W, Mitchell HA, Eichenberger SC, Wagner DD. Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: role of P-selectin. Blood 2005; 106: 2334-9
193. Larsen GR, Sako D, Ahern TJ, et al. P-selectin and E-selectin. Distinct but overlapping leukocyte ligand specificities. J Biol Chem 1992; 267 (16), 11104-10.
194. Scialla JJ, Plantinga LC, Kao WH, et al. Soluble P-selectin levels are associated with cardiovascular mortality and sudden cardiac death in male dialysis patients. Am J Nephrol 2011; 33(3): 224-30.
195. Rondaij MG, Bierings R, Kragt A, et al. Dynamics and plasticity of Weibel-Palade bodies in endothelial cells. Arterioscler Thromb Vasc Biol. 2006; 26(5): 1002-7.
196. Chauhan AK, Kisucka J, Brill A, et al. ADAMTS13: a new link between thrombosis and inflammation. J Exp Med 2008, 205(9): 2065-74
197. Fiedler U, Scharpfenecker M, Koidl S, et al. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 2004; 103: 4150-6.
198. Øynebråten I, Bakke O, Brandtzaeg P, et al. Rapid chemokine secretion from endothelial cells originates from 2 distinct compartments. Blood 2004; 104(2): 314-20.
199. Valentijn KM, Sadler JE, Valentijn JA, et al. Functional architecture of Weibel-Palade bodies. Blood 2011; 117(19): 5033-43.
200. Babich V, Knipe L, Hewlett L, et al. Differential effect of extracellular acidosis on the release and dispersal of soluble and membrane proteins secreted from the Weibel-Palade body. J Biol Chem 2009; 284(18): 12459-68.
201. Djordjevic T, Pogrebniak A, BelAiba RS, et al. The expression of the NADPH oxidase subunit p22phox is regulated by a redoxsensitive pathway in endothelial cells. Free Radic Biol Med 2005; 38(5): 616-30.
202. Thakur S, Du J, Hourani S, et al. Inactivation of adenosine A2A receptor attenuates basal and angiotensin II-induced ROS production by Nox2 in endothelial cells. J Biol Chem 2010; 285(51): 40104-13.
203. Kovacic HN, Irani K, Goldschmidt-Clermont PJ. Redox regulation of human Rac1 stability by the proteasome in human aortic endothelial cells. J Biol Chem 2001; 276: 45856-61
204. Li WG, Miller FJ Jr., Zhang HJ, et al. H2O2-induced O2 production by a non-phagocytic NAD(P)H oxidase causes oxidant injury. J Biol Chem 2001; 276: 29251-56